Y. Hei
Binzhou University(CN)Beijing Jiaotong University(CN)Ningxia Medical University(CN)Ningxia Medical University General Hospital(CN)Xijing Hospital(CN)Qilu Hospital of Shandong University(CN)The Fourth People's Hospital of Ningxia Hui Autonomous Region(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Bone health and treatments, Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Prostate Cancer Treatment and Research
Most-Cited Works
- → Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors(2005)564 cited
- → A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer(2012)189 cited
- → A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer(2011)91 cited
- → Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis(2014)45 cited
- → Simulations Using a Drug–Disease Modeling Framework and Phase II Data Predict Phase III Survival Outcome in First-Line Non–Small-Cell Lung Cancer(2012)34 cited
- → Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: Analysis based on prior history of skeletal complications